- Market Realist•11 minutes ago
In Russia, Teva Pharmaceutical has created a strong portfolio of about 300 products and has been extensively developing its research pipeline.
- Investor's Business Daily•16 hours ago
Amgen will likely beat Eli Lilly, Alder and Teva to market with an antibody-blocking migraine med.
- 24/7 Wall St.•16 hours ago
September 29, 2016: Here are four stocks trading with relatively heavy volume among 42 equities making new 52-week lows in Thursday’s session. NYSE decliners led advancers by 3 to 1 and Nasdaq decliners ...
Teva Pharmaceutical Industries Limited (TEVA)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||46.29 x 500|
|Ask||46.98 x 100|
|Day's Range||46.08 - 48.88|
|52wk Range||46.08 - 66.55|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||30.92|
|Avg Vol (3m)||6,060,471|
|Dividend & Yield||1.36 (2.79%)|